Trending...
- Work 365 Deepens TD SYNNEX Integration with Automated Azure Billing
- 54 Million Contract. New Chapter as AI Cybersecurity Platform Expands, Margins Surge & Management Signals Confidence. Cycurion, Inc: (NAS DAQ: CYCU)
- Badanamu and Friends Live Brings Hit Animated Series to Stages Across the United States
PHILADELPHIA--(BUSINESS WIRE)--Audacy announced a multiplatform partnership with mental health innovator Genomind. This breakthrough partnership taps into Audacy's influencers and Genomind's personalized genetic insights to bring mental health conversations into the mainstream.
As part of the partnership, Audacy will leverage the deep local connection of 15 stations across eight markets – Baltimore, Dallas, Houston, Los Angeles, New York, Philadelphia, San Diego and Washington D.C. – to promote Genomind's new Mental Health Map™, the first and only consumer DNA test to offer a concise, easy-to-navigate blueprint of your genetic profile and its influence on stress and anxiety, mood, focus and memory, habits and substance use, sleep, social behavior, and eating behavior.
Audacy and Genomind align in shared commitment to end the stigma surrounding mental health. Audacy's trusted voices and influencers will serve as ambassadors for the campaign – sharing their first hand experiences, using the Mental Health Map to learn more about their genetic makeup and predispositions toward mental health and wellness traits. Audacy is also among the first to provide Genomind as an employee benefit to help drive more engagement and action in mental health and wellness.
"Mental health awareness is a major area of focus for us and a crucial pillar of our companywide social impact platform, and we're excited to further activate our commitment through this partnership with Genomind," said Sarah Harris, Vice President, Social Impact, Audacy. "We recognize our significant influence and welcome the opportunity to use our voice, coupled with Genomind's mental health expertise, innovations and technology, to help improve and save lives and continue our shared mission of ending the stigma of talking about mental health."
More on The PennZone
"Genomind works to help all of us understand our personal mental health wiring and give people new insights and tools to manage and promote personalized mental health and wellness," said Kip Olmstead, President, Genomind. "Our partnership with Audacy scales our work allowing us to bring new mental health solutions to millions of Americans who may be suffering in silence or unsure of how to get started. Audacy's leadership in mental health is impressive and we are thrilled to find such a progressive and purpose-driven partner."
Genomind will also serve as the sponsor for Audacy's "I'm Listening Daily Capsules," 60-second daily public service announcements as part of the company's yearlong "I'm Listening" mental health initiative. Genomind will also serve as the presenting sponsor of Audacy's annual "I'm Listening" broadast, a live national program that brings together artists, athletes and medical specialists every September to remind listeners it's okay to not be okay, raise awareness and end the stigma of talking about mental health.
Audacy is committed to supporting the health and success of the communities that are the heart of its business. "I'm Listening" is a part of Audacy Serves, the Company's social impact platform that raises awareness of social issues and brings communities together for good. Audacy unites with its listeners and brands to support sound communities through several pillars of impact: mental health and anti-bullying, veterans and service members, children's health, the environment, civic education, and diversity, equity and inclusion.
More on The PennZone
About Audacy
Audacy, Inc. (NYSE: AUD) is a scaled, multi-platform audio content and entertainment company with the country's best radio broadcasting group, a leader in virtually every segment of audio, and America's #1 creator of original, premium audio. Audacy engages over 170 million consumers each month, bringing people together around the news, sports, podcasts and music that matter to them. Learn more at www.audacyinc.com, Facebook (Audacy Corp) and Twitter (@AudacyCorp).
About Genomind
Genomind is a leading precision mental health company singularly focused on filling the innovation gap in mental health care through novel, genetics-based tools. Supported by a world-class genetics lab, a unique heritage of clinical mental health expertise, clinical collaboration and consultation, state-of-the-art digital tools and telemental health enabling services, Genomind is empowering a new standard of care. Its flagship product, Genomind® Professional PGx Express™, is the most comprehensive pharmacogenetic testing service helping medical professionals personalize patients' mental health treatment. The Company also recently launched GenMed✓ Pro™ – Genomind's Smarter Precision Gene-Drug Interaction Software. This advanced medication management software was designed to help health professionals make safer prescribing decisions with speed and precision. In 2020 the company introduced the Genomind Mental Health Map™ – a breakthrough direct-to-consumer test that enables a new and better understanding of the biological basis of mental wellness, coupled with personalized actionable guidance to help people improve health and wellness. Learn more at https://www.genomind.com/.
As part of the partnership, Audacy will leverage the deep local connection of 15 stations across eight markets – Baltimore, Dallas, Houston, Los Angeles, New York, Philadelphia, San Diego and Washington D.C. – to promote Genomind's new Mental Health Map™, the first and only consumer DNA test to offer a concise, easy-to-navigate blueprint of your genetic profile and its influence on stress and anxiety, mood, focus and memory, habits and substance use, sleep, social behavior, and eating behavior.
Audacy and Genomind align in shared commitment to end the stigma surrounding mental health. Audacy's trusted voices and influencers will serve as ambassadors for the campaign – sharing their first hand experiences, using the Mental Health Map to learn more about their genetic makeup and predispositions toward mental health and wellness traits. Audacy is also among the first to provide Genomind as an employee benefit to help drive more engagement and action in mental health and wellness.
"Mental health awareness is a major area of focus for us and a crucial pillar of our companywide social impact platform, and we're excited to further activate our commitment through this partnership with Genomind," said Sarah Harris, Vice President, Social Impact, Audacy. "We recognize our significant influence and welcome the opportunity to use our voice, coupled with Genomind's mental health expertise, innovations and technology, to help improve and save lives and continue our shared mission of ending the stigma of talking about mental health."
More on The PennZone
- Parents No Longer Have to Wait 3 Weeks for a Sleep Consultant: Nora Talks Tonight, Stays for 5 Days, Costs $89
- May The Worst Team Win! Loserball Kicks Off Another NFL Season of Hilarious Mayhem
- Black Women Living With, and Impacted by, HIV Express Gratitude, Grief, Joy, and Resilience
- MainConcept Easy Video API Extends Full Transcoding to Arm and NETINT VPUs
- Cruxy shortlisted for two Private Equity Wire® US Awards 2026: Advisory Firm of the Year (Overall) & Value Creation Consulting Firm of the Year
"Genomind works to help all of us understand our personal mental health wiring and give people new insights and tools to manage and promote personalized mental health and wellness," said Kip Olmstead, President, Genomind. "Our partnership with Audacy scales our work allowing us to bring new mental health solutions to millions of Americans who may be suffering in silence or unsure of how to get started. Audacy's leadership in mental health is impressive and we are thrilled to find such a progressive and purpose-driven partner."
Genomind will also serve as the sponsor for Audacy's "I'm Listening Daily Capsules," 60-second daily public service announcements as part of the company's yearlong "I'm Listening" mental health initiative. Genomind will also serve as the presenting sponsor of Audacy's annual "I'm Listening" broadast, a live national program that brings together artists, athletes and medical specialists every September to remind listeners it's okay to not be okay, raise awareness and end the stigma of talking about mental health.
Audacy is committed to supporting the health and success of the communities that are the heart of its business. "I'm Listening" is a part of Audacy Serves, the Company's social impact platform that raises awareness of social issues and brings communities together for good. Audacy unites with its listeners and brands to support sound communities through several pillars of impact: mental health and anti-bullying, veterans and service members, children's health, the environment, civic education, and diversity, equity and inclusion.
More on The PennZone
- September Is Healthy Aging® Month Announces 2026 Theme: "Curiosity Has No Age Limit"
- Lake Norman Philharmonic - Free Community Concert
- Amaris Mint® Confirms UK Availability of Swedish-Made BioBoost Daily Nutrition Range
- Sea Tales Strengthens U.S. Leadership Team as Retail Expansion Accelerates
- Patented Foodservice Products Company with Strong Gross Margins and Substantial Two-Year Revenue Growth Hits Market for $1.6 Million
About Audacy
Audacy, Inc. (NYSE: AUD) is a scaled, multi-platform audio content and entertainment company with the country's best radio broadcasting group, a leader in virtually every segment of audio, and America's #1 creator of original, premium audio. Audacy engages over 170 million consumers each month, bringing people together around the news, sports, podcasts and music that matter to them. Learn more at www.audacyinc.com, Facebook (Audacy Corp) and Twitter (@AudacyCorp).
About Genomind
Genomind is a leading precision mental health company singularly focused on filling the innovation gap in mental health care through novel, genetics-based tools. Supported by a world-class genetics lab, a unique heritage of clinical mental health expertise, clinical collaboration and consultation, state-of-the-art digital tools and telemental health enabling services, Genomind is empowering a new standard of care. Its flagship product, Genomind® Professional PGx Express™, is the most comprehensive pharmacogenetic testing service helping medical professionals personalize patients' mental health treatment. The Company also recently launched GenMed✓ Pro™ – Genomind's Smarter Precision Gene-Drug Interaction Software. This advanced medication management software was designed to help health professionals make safer prescribing decisions with speed and precision. In 2020 the company introduced the Genomind Mental Health Map™ – a breakthrough direct-to-consumer test that enables a new and better understanding of the biological basis of mental wellness, coupled with personalized actionable guidance to help people improve health and wellness. Learn more at https://www.genomind.com/.
0 Comments
Latest on The PennZone
- VC Fast Pitch and Steamwork Ventures Bring Startup & Investor Networking Event to Santa Barbara on October 8
- Volant Announces Major Partnership with the STEM Racing Canada Program to CHAMPION YOUTH ENGINEERING
- Badanamu and Friends Live Brings Hit Animated Series to Stages Across the United States
- 54 Million Contract. New Chapter as AI Cybersecurity Platform Expands, Margins Surge & Management Signals Confidence. Cycurion, Inc: (NAS DAQ: CYCU)
- MommyAndMe.club Expands Parent-Child Class Directory to All 50 States and Washington, D.C
- Work 365 Deepens TD SYNNEX Integration with Automated Azure Billing
- Award-Winning Author's New Timely Book "Philly Girl" Highlights Centuries of Brave & Bold Women from Philadelphia
- RAS AP Consulting Signals Growth of Managed AP Governance With Digital Expansion, Pipeline Activation, and Trademark Filing Ahead of Esker All Access
- National Nonprofit Lights 200 Landmarks Pink and Blue for Pregnancy and Infant Loss Awareness Month
- Vegan Kingz Unveils Upgraded Digital Platform to Streamline Commercial Foodservice & Wholesale Ordering
- Steve Thompson Launches StickyHealth to Tackle the Retention Gap in the Growing GLP 1 Market
- Qscription Technologies Appoints Dr. Kimberly Beavers as Founding Clinical Advisor
- When Hope Feels Gone, Death2life Is Still Here!
- Sebastian Stroeller Publishes "The MAP Language Canon" — The Complete Practitioner's Guide to Structural Conversation
- OneVizion Appoints Zebra Technologies CIO Matt Ausman to Board of Directors
- GLADYS Magazine Celebrates their 18 Year Anniversary!
- New Townhome Building Released at Heritage at South Brunswick, Offering Private Perimeter Setting and Water Views
- Comics Veteran on Return of Teenage Mutant Ninja Turtles Characters, 3-D Projects, Collaboration with Original 'Star Wars' Toy Engineer
- Flexible Plan Investments Announces Retirement of Executive Vice President Renée Toth
- Sensory Education launches new neuro-affirming psychoeducation book, Sensory Diversity